Breast Metastatic Localization of Signet-Ring  Cell Gastric Carcinoma by Parrell Soler, C. et al.
International Scholarly Research Network
ISRN Obstetrics and Gynecology
Volume 2011, Article ID 426150, 3 pages
doi:10.5402/2011/426150
Case Report
BreastMetastatic Localization ofSignet-Ring
CellGastricCarcinoma
C. ParrellSoler, A. PalaciosMarqu´ e s ,L .S ac oL´ opez, R. Bermejo De las Heras,
and S. Pertusa Mart´ ınez
Servicio de Obstetricia y Ginecolog´ ıa, Hospital Marina Baixa, Avenida Alcalde En Jaume Botella Major 7,
03570 Villajoyosa (Alicante), Spain
Correspondence should be addressed to S. Pertusa Mart´ ınez, salvador pertusa@yahoo.es
Received 26 August 2010; Accepted 21 October 2010
Academic Editor: C. Mundhenke
Copyright © 2011 C. Parrell Soler et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Metastatic tumors in the breast are quite rare and constitute 0,5 to 6% of all breast malignancies. They often occur in a
polymetastatic context. Gastrointestinal lesions rarely metastasize to the breast. The ﬁrst case of a metastasis deposit to the breast
and ovary from gastric signet-ring cell carcinoma was reported in the literature in 1999. Since this report, only 5 cases have been
reported. We present a case report of a 37-year-old woman who complained of a lump in the left breast. Two months earlier, the
woman underwent a subtotal gastrectomy and a total hysterectomy with double anexectomy, which histologically was diagnosed
of gastric signet-ring carcinoma, disseminated with Krukenberg’s tumor. In those days, the patient was following a chemotherapy
treatment. A core needle biopsy of the lesion in left breast revealed cells with signet-ring features, with probably gastric origin.
1.CaseReport
A37-year-oldwomancomplainedofalumpintheleftbreast.
Two months earlier, the woman underwent a subtotal gas-
trectomy and a total hysterectomy with double anexectomy.
Thepathologicﬁndingswerediagnosticofgastricsignet-ring
carcinoma, disseminated with Krukenberg’s tumor. In those
days, the patient was following a chemotherapy treatment.
The examination showed an irregular area of induration,
of 4cm approximately, in lower inner quadrant of the left
breast Figure 1, without evidence of lymphadenopathy. The
mammography revealed asymmetric density in the lower
inner quadrant of the left breast, without evidence of axillary
or supraclavicular lymphadenopathy. The ultrasound exam
showed a solid 1.5cm node suspicious of malignancy.
A core needle biopsy of the lesion in the left breast
revealed cells with signet-ring features, with probably gastric
origin Figure 2.
The histopathological features were CK 7 positive and C-
ERB-B2, CK 20, ER, and PR negative.
The breast metastasis responded well to chemotherapy,
and the size was reduced in posterior controls, but cancer
progressed with peritoneal dissemination that required to be
removed. The progression was ﬁnally irreversible, and the
woman needed palliative care.
The patient died 7 months after the breast metastasis was
diagnosed and 9 months after the gastric tumor.
2. Discussion
Metastatic tumors in the breast are quite rare and constitute
0,5% to 6% of all breast malignancies. They often occur in a
polymetastaticcontext[1].Approximately300casesofbreast
metastases from extramammary sites have been reported
[2]. The most frequent primitive tumors are lymphoma,
leukaemia, and malignant melanoma [1, 3].
Gastrointestinal lesions rarely metastasize to the breast
[3]. The ﬁrst case of a metastasis deposit in the breast and
ovary from gastric signet-ring cell carcinoma was reported
in the literature in 1999 [4].
Since this report, only 5 cases have been reported [5].
Selective invasion of hormone-dependent organs seems
quite intriguing, especially in premenopausal women.
Increased blood supply of the breast has been proposed2 ISRN Obstetrics and Gynecology
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Figure 1: The mammography revealed asymmetric density in the
lower inner quadrant of the left breast.
as the mechanism for the increased incidence of breast
metastasis in premenopausal women. On the other hand,
gastric cancer seems to have a more aggressive biologic
behaviour in younger age groups, where hormonal factors
are implicated [2].
The average age of patients at the time of presentation of
breast metastases is 47 years [2].
On mammography, the metastatic lesions may appear as
benign lesions, well circumscribed masses with no microcal-
ciﬁcations. The metastatic lesions are usually palpable and
most often located in the upper outer quadrant of the left
breast. Breast involvement is bilateral in 25% of the cases,
and there is concomitant axillary lymph node enlargement
in up to 15%. The occurrence of multiple tumor nodules is
unusual. We must bear in mind that in up to 25% of patients
the primary lesion has not been diagnosed yet and the palpa-
ble mass could be the ﬁrst sign of an unknown disease [2, 5].
In cases of breast inﬂammation or lumps, biopsy should
be performed, even in the presence of an extramammary
neoplasm [5].
Histopathologic examination of the lesion may be usefull
by distinguishing a primary breast cancer from a metastatic
gastrointestinal tumor. The metastases from stomach ade-
nocarcinomas are usually positive for CEA and cytokeratin
7 and 20 (CK) and negative for estrogen receptor (ER)
and progesterone receptor (PR), as well as for C-ERB-B2
(in up to 20% it can be positive). Thus, the combination
Figure 2: Marked ﬁbrosis with the presence of loose cells of big size
and wide cytoplasm, positive with PAS technique. The morphology
is comparable to the gastric carcinoma diagnosed two months
earlier.
of CK 20 and CEA positive staining in conjunction with
negative ER staining strongly supports a diagnosis consistent
with gastrointestinal primary adenocarcinoma rather than a
primary breast carcinoma [2, 3, 5, 6].
The histopathological features in our case were CK 7
positive and C-ERB-B2, CK 20, ER, and PR negative.
Wide local resection, radiation, and axillary node dissec-
tion are far from being on appropriate therapy for metastatic
gastrointestinal cancer to the breast, which is associated with
a poor prognosis (approximately 80% of patients die within
1 year of diagnosis) [3, 7].
It seems that the tumoral resection of primary lesion
and local tumoral extension improves the survival beneﬁts
of these patients, specially when an optimal cytoreductive
operation is performed [8, 9].
Our patient presented gastric signet-ring carcinoma,
disseminatedwithKrukenberg’stumor.Alltheselesionswere
removed. When the breast metastasis was diagnosed, the
patient was treated with chemotherapy, and it was decided
to keep the same treatment. The breast metastasis responded
well to chemotherapy, and its size was reduced in subsequent
monitoring, but cancer progressed with peritoneal dissemi-
nation that was required to be removed. The progression was
ﬁnally irreversible, and the woman needed palliative care.
Breast metastases with gastrointestinal primary lesion
have a poor prognosis, specially those of gastric origin
[7, 8, 10, 11].
Sato et al. reported two cases of breast metastasis from
gastric malignant disease and marked that breast metastasis
is a sign of poor prognosis of the primary malignant disease.
The possibility of breast metastasis should be considered in
appropriate patients to preclude unnecessary major surgery
[7].
Other report of four cases of breast metastases from
extramammary malignancies showed that the development
of breast metastases indicates the lethal nature of blood-
bornemetastasesinthenaturalevolutionofaprimarytumor
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Cheong et al. [10] studied the median survival time
of patients after gastric resection and metastasectomy. The
median survival time in the resection group was 17 months,
which was signiﬁcantly longer than that in the nonresection
group, with a median survival duration of all the patients of
9 months.
Krukenberg’s tumors of gastric origin have a poor
prognosis [10, 11]. A study of Kim et al. with 34 female
patients estimated a median survival period of 7,7 months
after diagnosis. Median survival periods according to the
extent of metastasis were 10,9 months for patients with
disease conﬁned to the ovaries, 13,1 months for patients
with disease conﬁned to the pelvis, 7,5 months for patients
with intra-abdominal disease, and 3,6 months for patients
with disease spread outside the abdomen and pelvis. It seems
that the absence of residual disease after treatment and
limited disease extent were favorable prognosis factors of
metachronous Krukenberg’s tumors of stomach origin [11].
Jiang et al. investigated survival impacts of metastasec-
tomy in woman with Krukenberg’s tumors of the ovary and
survival beneﬁts in diﬀerent origins. There was a signiﬁcant
diﬀerence in survival between patients with metastatic
disease conﬁned to the ovaries and those with extensive
metastases, with an estimated median survival of 30, 7, and
10 months, respectively [8].
Our patient died 7 months after breast metastasis
diagnosis and 9 months after primary disease diagnosis.
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